Yestino - The Signal · Lilly Zepboundhttps://yestino.com/zh-CN/entities/lilly-zepbound-780493与 Lilly Zepbound 相关的全部事件zh-CNViking's obesity drug data fuels bets it can rival Lilly's Zepboundhttps://yestino.com/zh-CN/events/viking-s-obesity-drug-data-fuels-bets-it-can-rival-lilly-s-z-70fc41https://yestino.com/zh-CN/events/viking-s-obesity-drug-data-fuels-bets-it-can-rival-lilly-s-z-70fc41Tue, 22 Sep 2026 17:14:03 GMTPatients who switched from weekly to monthly injections of VK2735 retained most of their weight loss, with side effects similar to placebo 来源：Quartz